RhoC is increasingly reported to be involved in the malignant potential of tumors, such as breast cancer [7], lung cancer [8], gastric cancer [9], colon cancer [10], prostate cancer [11], and head and neck squamous cell carcinoma (HNSCC) [12]. Here, RHOC is linked to Familial prostate cancer.